Arbutus Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.About ABUS
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses.
ABUS Key Statistics
ABUS News
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus Biopharma Corporation misses on earnings expectations. Reporte...
Arbutus Biopharma ( ) First Quarter 2024 Results Key Financial Results Revenue: US$1.53m (down 77% from 1Q 2023). Net loss: US$17.9m (loss widened by 9.4% fr...
Arbutus Biopharma (ABUS) has released an update. Arbutus Biopharma Corporation announced the retirement of its co-founder and Chief Scientific Officer, Dr. Mic...
More ABUS News
Arbutus Biopharma (ABUS) has released an update. Arbutus Biopharma has reported positive developments in their first quarter of 2024, including promising trial...
Reports Q1 revenue $1.532M, consensus $2.15M. “We continued to make progress in the first quarter of 2024 in advancing our pipeline of HBV assets,” said Michael...
Arbutus Biopharma announced that after a distinguished 38-year career, the Company’s co-founder and Chief Scientific Officer, CSO, Dr. Michael Sofia, will retir...
Arbutus Biopharma Corporation WARMINSTER, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a cl...
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Arbutus Biopharma (AB...
